LPL Financial’s Zymeworks ZYME Stock Holding History

LPL Financial’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,126	Closed	-$240K	–	5043
2023 Q4	$240K	Buy	+23,126	New	+$184K	﹤0.01%	4257

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

LPL Financial's ZYME Position: Q1 2024 in Review

LPL Financial sold out of Zymeworks (ZYME) in Q1 2024, closing a stake of 23,126 shares — an estimated $240K sold.

LPL Financial first reported a position in ZYME in Q4 2023 and held it in 1 quarter. The position peaked at $240K in Q4 2023. 171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

LPL Financial reported no remaining Zymeworks position as of Q1 2024 after selling out during the quarter.
LPL Financial sold 23,126 Zymeworks shares in Q1 2024, an estimated $240K.
LPL Financial first reported a position in Zymeworks in Q4 2023 and held it in 1 quarter.
LPL Financial's Zymeworks position peaked at $240K in Q4 2023.
171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on LPL Financial's 13F filing for Q1 2024, filed 10 May 2024.